Dr. Bruce Rankin has been on the front lines of COVID-19 vaccination testing

DeLand’s Dr. Bruce Rankin is the Florida Osteopathic Medical Association’s “Physician of the Year” for 2022. Having spent more than 30 years as a doctor in DeLand, and more than 20 years in vaccine testing and other medical procedures, Rankin has been on the front lines of battling COVID-19 since 2020.

Rankin was officially recognized as Physician of the Year at the Florida Osteopathic Medical Association conference in Fort Lauderdale last month.

“It’s an honor to be recognized by your colleagues and peers for the state of Florida for recognition like this,” Rankin said. “It was nice to be recognized.”

He believes his involvement in COVID-19 vaccine testing with his firm, Accel Clinical Research in DeLand, played a role in his being recognized by the medical association. Accel was one of just two clinics nationwide selected to perform clinical trials of the Pfizer- and Moderna-produced COVID-19 vaccines, Rankin said, and one of a small pool across the world testing those vaccines along with the Johnson & Johnson vaccine and the yet-to-be-authorized Novavax COVID-19 vaccine.

“It was kind of a very good thing for our size community to be involved with. It has global effects,” Rankin told The Beacon. “I was very honored to be awarded some of these trials to work on.”

His wife, Jeannette Rankin, is awfully proud of her husband, too.

Since the pandemic began, she has seen her husband work incredibly hard to contribute to the development of the COVID-19 vaccines.

“It’s been two years of him working every weekend, just about, coming home at 7-8 o’ clock at night. People have no concept of what he and that whole facility did to get these vaccines approved,” she said. “All I could basically do when he got home was feed him and tell him to go to bed.”

Vaccine trials are still ongoing, too, with participants continuing to report their experiences since they first joined the voluntary study in 2020. Among the COVID-19 vaccines Accel is testing is a not-yet-approved vaccine known as Novavax. The Novavax vaccine is, according to Yale University, easier to produce than some of the other vaccines for COVID-19 and can be stored at warmer temperatures, too.

2 COMMENTS

  1. Congratulations many times over for your excellent research and your caring engagement as a physician. You have made a difference in our lives and wellness that goes beyond words. All the best for a great future.

LEAVE A REPLY

Please enter your comment!
Please enter your name here